Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin

The dynamic interaction of planktonic and biofilm cells of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin was investigated in a chemostat system. The results indicated that planktonic and young biofilm cells of the 2-day-old chemostat culture of P. aeruginosa were susceptible to killing by chemostat-controlled doses of either 250 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml or 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of the planktonic and young biofilm cells was observed after exposure of the cells to six chemostat-controlled doses of these antibiotic at 8-h intervals for 7 days. Regrowth of the organism was not observed after the termination of antibiotic therapy on day 7. A different picture was observed when antibiotic treatment was initiated on day 10 after inoculation. Viable old biofilm cells were reduced to approximately 20% after exposure to the chemostat-controlled doses of 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of old biofilm cells could not be achieved, and regrowth of the organism occurred after the termination of antibiotic therapy. These data suggest that young biofilm cells of mucoid P. aeruginosa can be effectively eradicated with the combination of piperacillin and tobramycin, while old biofilm cells are very resistant to these antibiotics and eradication of old biofilm cells is not achievable with the chemostat-controlled doses of piperacillin and tobramycin used in this study.

[1]  J. Klastersky,et al.  Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections , 1972, Antimicrobial Agents and Chemotherapy.

[2]  J. Costerton,et al.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis , 1980, Infection and immunity.

[3]  W. Nichols,et al.  Antibiotic penetration through bacterial capsules and exopolysaccharides. , 1982, The Journal of antimicrobial chemotherapy.

[4]  N. HØiby,et al.  ANTIMICROBIAL CHEMOTHERAPY IN CYSTIC FIBROSIS PATIENTS , 1982 .

[5]  P. Lambert,et al.  Evidence that mucoid Pseudomonas aeruginosa in the cystic fibrosis lung grows under iron-restricted conditions , 1984 .

[6]  G. Pier Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. , 1985, The Journal of infectious diseases.

[7]  B. Iglewski,et al.  The contribution of exoproducts to virulence of Pseudomonas aeruginosa. , 1986, Canadian journal of microbiology.

[8]  M. Vasil Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. , 1986, The Journal of pediatrics.

[9]  P. Lexa,et al.  Artifacts in dilution pharmacokinetic models caused by adherent bacteria , 1986, Antimicrobial Agents and Chemotherapy.

[10]  T. Platt Microbiological assay of antibiotics in body fluids and tissues , 1986 .

[11]  G. Shand,et al.  Media for study of growth kinetics and envelope properties of iron-deprived bacteria , 1987, Journal of clinical microbiology.

[12]  A. Chakrabarty,et al.  Alginate Biosynthesis: A Model System for Gene Regulation and Function in Pseudomonas , 1987, Bio/Technology.

[13]  J. Costerton,et al.  Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.

[14]  H L Walmsley,et al.  The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. , 1989, Journal of general microbiology.

[15]  J. Costerton,et al.  Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system , 1989, Antimicrobial Agents and Chemotherapy.

[16]  H. Anwar,et al.  Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. , 1989, The Journal of antimicrobial chemotherapy.

[17]  M. V. van Loosdrecht,et al.  Influence of interfaces on microbial activity. , 1990, Microbiological reviews.

[18]  J. Costerton,et al.  Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa , 1990, Antimicrobial Agents and Chemotherapy.

[19]  S. Roychoudhury,et al.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients , 1991, Clinical Microbiology Reviews.